Discover 7 treatments for ischemic heart disease that are saving lives. From cutting-edge medications to advanced procedures changing cardiac care forever.

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

Belgian company Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216, a ...

New drug lorundrostat shows promising results in lowering blood pressure for patients with resistant hypertension.

A recent study published in Engineering has shed light on the relationship between gut microbiota, isoflavones, and ...

Per 100 gms of boiled papaya contains 39-42 calories, 10.2 g carbs. 6.5-6.7 g sugar, 1.5 g dietary fiber, 0.4-0.5 g protein, ...

These enzymes are inhibited by several classes of compounds, such as sulphonamides, sulphamates and sulphamides, among others. The inhibitors bind to the catalytic zinc ion within the enzyme cavity.

A new Ludwig Cancer Research study could help explain why drugs known as PI3 kinase (PI3K) inhibitors haven’t led to ...

A study published in Engineering reveals that gut microbiota and isoflavones in soy products may have a role in alleviating geniposide ...

Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.